insights_auto
Why is 45E up 3.11%?
Dive Deeperchevron_right
45E:FRA
Natera Inc
€361.70
arrow_upward
+3.11%(+10.90) 1D
Sep 25, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 45E...
Open
€358.00
High
€363.80
Low
€358.00
Mkt. cap
59.47B
Avg. vol.
17.00
Volume
22.00
52-wk high
€363.80
52-wk low
€158.00
No. of employees
6K
Open
€358.00
High
€363.80
Low
€358.00
Mkt. cap
59.47B
Avg. vol.
17.00
Volume
22.00
52-wk high
€363.80
52-wk low
€158.00
No. of employees
6K
News stories
From web sources and news partners
Investing.com Nigeria
·
14 hours ago
Form 4 Natera Inc For: 25 September By Investing.com
Investing.com
·
14 hours ago
Natera director Sheena’s trusts dispose of $7.0m in NTRA stock
Stock Titan
·
15 hours ago
Under a preset plan, two trusts sold 18,064 Natera (NTRA) shares in 12 transactions.
AD HOC NEWS
·
2 days ago
Natera stock gains 2.75 percent after Japan test approval
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com